Association of Personal Characteristics and Effectiveness of Immunotherapy in Late-Stage Non-Small Cell Lung Cancer: A Systematic Review.

JNCI Cancer Spectr · 2022 · PMC8935137 · PMID 35603843

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

For subgroups of patients aged younger than 65 years, all experimental studies except CheckMate 026 ( 20 ) showed a trend toward improved survival with receipt of immunotherapy, even if the improvement in survival was not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.